Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Accumulated Expenses (2016 - 2025)

Standard Biotools (LAB) has disclosed Accumulated Expenses for 16 consecutive years, with $18.1 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 1047.75% to $18.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.1 million through Dec 2025, up 1047.75% year-over-year, with the annual reading at $18.1 million for FY2025, 1047.75% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $18.1 million at Standard Biotools, up from $13.6 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $31.9 million in Q2 2024, with the low at $1.6 million in Q4 2024.
  • Average Accumulated Expenses over 5 years is $13.5 million, with a median of $9.6 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses crashed 86.88% in 2024, then surged 1047.75% in 2025.
  • Over 5 years, Accumulated Expenses stood at $8.7 million in 2021, then increased by 5.53% to $9.2 million in 2022, then skyrocketed by 31.67% to $12.1 million in 2023, then plummeted by 86.88% to $1.6 million in 2024, then soared by 1047.75% to $18.1 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $18.1 million, $13.6 million, and $24.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.